SEC Company Response from CNBX Pharmaceuticals (CNBX) — Apr 7, 2015
CNBX Pharmaceuticals Inc.
Date: April 7, 2015 · CIK: 0001343009 · Accession: 0001019687-15-001325
AI Filing Summary & Sentiment
File numbers found in text: 000-52403
Letter
Re: Cannabics Pharmaceuticals Inc. Form 10-K for the Fiscal Year Ended August 31, 2014 Filed December 15, 2014 File No. 000-52403
Dear Ms. Marlowe,
The Issuer is currently preparing its responses to your above-referenced Comments. As we have recently engaged a new financial aid and are preparing for the upcoming Q, we realized that some of your points & the issuer’s answers are actually affecting the drafting of this Q. In order to provide a more thorough and complete set of answers, we are requesting an extension of our Answers to these comments. We would expect to have them presented to you before or by end of next Friday, 17th April.
Should you have any questions or comments, please do contact me at any time. Thank you for your assistance in this matter.
Sincerely
yours,
David E.
Price, Esq.
Show Raw Text
CORRESP 1 filename1.htm #3 BETHESDA METRO CENTRE SUITE 700 BETHESDA, MD 20814 --------- Tel (877) 424-2429 Cannabics.com 7th April, 2015 US Securities & Exchange Commission Corporate Finance Division Washington, DC 20549 Attn: Ms. Julie Marlowe Re: Cannabics Pharmaceuticals Inc. Form 10-K for the Fiscal Year Ended August 31, 2014 Filed December 15, 2014 File No. 000-52403 Dear Ms. Marlowe, The Issuer is currently preparing its responses to your above-referenced Comments. As we have recently engaged a new financial aid and are preparing for the upcoming Q, we realized that some of your points & the issuer’s answers are actually affecting the drafting of this Q. In order to provide a more thorough and complete set of answers, we are requesting an extension of our Answers to these comments. We would expect to have them presented to you before or by end of next Friday, 17th April. Should you have any questions or comments, please do contact me at any time. Thank you for your assistance in this matter. Sincerely yours, David E. Price, Esq.